Cargando…
A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants
BACKGROUND: The management of a patent ductus arteriosus in preterm infants continues to be debated among neonatologists due to the absence of concrete evidence that precisely weighs the long term outcomes of active, early intervention against a conservative approach. In the majority of institutions...
Autores principales: | AlFaleh, Khalid, Alluwaimi, Eman, AlOsaimi, Ahlam, Alrajebah, Sheikha, AlOtaibi, Bashayer, AlRasheed, Fatima, AlKharfi, Turki, Paes, Bosco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414008/ https://www.ncbi.nlm.nih.gov/pubmed/25895495 http://dx.doi.org/10.1186/s12887-015-0353-4 |
Ejemplares similares
-
A decision aid for considering indomethacin prophylaxis vs. symptomatic treatment of PDA for extreme low birth weight infants
por: AlFaleh, Khalid M, et al.
Publicado: (2011) -
Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice
por: Mosalli, Rafat, et al.
Publicado: (2009) -
Indomethacin induced ductus arteriosus closure in midgestation fetus
por: Beaute, Jeanette I., et al.
Publicado: (2018) -
Neonatal Short-Term Outcomes of Gestational Diabetes Mellitus in Saudi Mothers: A Retrospective Cohort Study
por: Al-Khalifah, R., et al.
Publicado: (2012) -
Gentamicin in Neonates with Hemodynamically Significant Patent Ductus Arteriosus
por: Sridharan, Kannan, et al.
Publicado: (2023)